Both medications work alongside healthy eating and exercise
According to a company statement, there have been hundreds of problems reported to the FDAs voluntary adverse event reporting system associated with compounded semaglutide
GLP-1 RA-based therapies confer cardiovascular benefits and favourable metabolic effects, such as weight loss [8, 9], with emerging evidence of kidney protection [8,9,10,11,12,12]
Include the full CMP, lipid panel, and HbA1c
As of September 2023, of the 23,845 reports of adverse reactions with semaglutide in the US, there have been 144 cases of suicidal ideation and 2 deaths by suicide